GRAL
GRAIL Inc.
$90.82
-$4.24(-4.46%)
54
Overall
60
Value
58
Tech
44
Quality
Market Cap
$2.97B
Volume
892.36K
52W Range
$16.10 - $115.76
Target Price
$105.00
Company Overview
| Mkt Cap | $2.97B | Price | $90.82 |
| Volume | 892.36K | Change | -4.46% |
| P/E Ratio | -1.5 | Open | $92.46 |
| Revenue | $125.6M | Prev Close | $95.06 |
| Net Income | $-2.0B | 52W Range | $16.10 - $115.76 |
| Div Yield | N/A | Target | $105.00 |
| Overall | 54 | Value | 60 |
| Quality | 44 | Technical | 58 |
No chart data available
About GRAIL Inc.
GRAIL, Inc., a commercial-stage healthcare company, focuses on developing technologies for early cancer detection in the United States and internationally. It provides Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. The company offers development services including support for ongoing clinical studies, pilot testing, research, and therapy development. It also develops minimal residual disease post-diagnostic tests. The company was incorporated in 2015 and is headquartered in Menlo Park, California.
Latest News
Grail Inc. Navigates Global Trade Challenges Amid Tariffs and Regulatory Hurdles
TipRanks Auto-Generated Newsdesk•a month ago
GRAIL Inc Announces $300M Equity Distribution Agreement
TipRanks Auto-Generated Newsdesk•a month ago
Analysts Are Bullish on Top NA Stocks: GRAIL Inc (GRAL), Sound Point Meridian Capital, Inc. (SPMC)
Brian Anderson•a month ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GRAL | $90.82 | -4.5% | 892.36K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |